FruiteX-B® Calcium Fructoborate (N152), FutureCeuticals’ flagship patented mineral complex, represents a significant nutritional breakthrough for joint and bone support. FruiteX-B® is stable, non-toxic, water-soluble and boasts clinically measured bioactivity and bioavailability, with over a dozen published studies on its unique properties and potential health benefits, especially for conditions linked to inflammation such as bone, joint, and cardiovascular conditions. Extensive and ongoing research indicates FruiteX-B® improves WOMAC and McGill scores in as little as 7 days.
FruiteX-B also contributes to healthy inflammatory responses, with several published clinical studies indicating significant reduction in C-Reactive Protein (CRP), a well-recognized general inflammatory marker.
A growing body of research also indicates that calcium fructoborate may also offer compelling contributions to bone health. Contact Us for more information and a copy of our bone health white paper.
FruiteX-B® Calcium Fructoborate is manufactured under US Patent #5,962,049 and issued and pending foreign patents and is available exclusively from VDF FutureCeuticals, Inc.